Want to see JP:2269 full AI Analyst Report?

Meiji Holdings Co (2269) Earnings Dates, Call Summary & Reports

Q: What is the P/E ratio of Meiji Holdings Co Ltd stock?

The P/E ratio of {name} is N/A.

2 Followers

Earnings Data

Report Date

Aug 11, 2026

TBA (Confirmed)

Period Ending

2027 (Q1)

Consensus EPS Forecast

53.09

Last Year’s EPS

37.27

Same Quarter Last Year

Analyst Consensus

―

Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025

Earnings Call Date:Nov 11, 2024|

% Change Since:

Earnings Call Sentiment|Neutral

The earnings call presented a mixed picture with strong performances in the Pharmaceutical segment and growth in certain brands, but faced challenges in the Food segment, particularly in China and the U.S. The decline in profits and the revised vaccine outlook were notable concerns.

Company Guidance

In the earnings call for Q2 2025, Meiji Holdings provided comprehensive guidance on its financial performance and future outlook. For the first half of fiscal 2024, the company reported consolidated net sales of JPY 569.0 billion, marking a 4.2% increase year-on-year. However, operating profit remained steady at JPY 44.3 billion, while profit attributable to owners of the parent decreased by 3.8% to JPY 26.8 billion due to lower extraordinary gains. The Food segment experienced a 2.2% increase in net sales to JPY 455.4 billion, although operating profit declined by 6.9% year-on-year, affected by increased raw material costs and challenges in overseas operations. Meanwhile, the Pharmaceutical segment saw a significant boost, with net sales rising by 12.9% to JPY 113.8 billion and operating profit increasing by 16.7% to JPY 18.5 billion, aided by strong sales of antibacterial injections and influenza vaccines. For the second half, Meiji plans to achieve a year-on-year increase in consolidated net sales to JPY 589.9 billion and an operating profit of JPY 41.6 billion, focusing on price adjustments and strategic marketing to counter cost pressures.

Increase in Consolidated Net Sales

Consolidated net sales for the first half of fiscal 2024 was JPY 569.0 billion, a year-on-year increase of 4.2%.

Pharmaceutical Segment Performance

Net sales in the Pharmaceutical segment totaled JPY 113.8 billion, a year-on-year increase of 12.9%. Operating profit in this segment increased by 16.7% year-on-year.

Advanced Shipment of Influenza Vaccines

Advanced shipment of influenza vaccines contributed JPY 1.3 billion to the increase in profit.

Growth in Antibacterial Drug Sales

Sales of antibacterial injection increased, positively impacting the Pharmaceutical segment's performance.

Strong Performance of Domestic Business

Growth in sales, including high-profit items, is expected to continue in the second half, mainly driven by the domestic business.

Strong Growth in Hello Panda Brand

Hello Panda is expected to achieve JPY 19.9 billion in sales for the fiscal year, showing strong growth, particularly in the U.S.

Meiji Holdings Co (JP:2269) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

JP:2269 Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 11, 2026	2027 (Q1)	53.09 / -	37.27	―	―	―
May 14, 2026	2026 (Q4)	3.34 / -13.82	26.7	-151.76% (-40.52)		―
Feb 12, 2026	2026 (Q3)	74.49 / 63.97	61.72	3.65% (+2.25)		―
Nov 13, 2025	2026 (Q2)	47.08 / 42.00	47.43	-11.45% (-5.43)
Aug 06, 2025	2026 (Q1)	49.70 / 37.27	50.23	-25.80% (-12.96)		―
May 09, 2025	2025 (Q4)	31.29 / 26.70	20.523	30.10% (+6.18)		―
Feb 10, 2025	2025 (Q3)	53.05 / 61.72	61	1.18% (+0.72)		―
Nov 11, 2024	2025 (Q2)	44.11 / 47.43	58.54	-18.98% (-11.11)
Aug 09, 2024	2025 (Q1)	38.67 / 50.23	41.59	20.77% (+8.64)		―
May 10, 2024	2024 (Q4)	19.85 / 20.52	79.421	-74.16% (-58.90)		―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

JP:2269 Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 14, 2026	¥3611.00	¥3589.00	-0.61%
Feb 12, 2026	¥3778.02	¥3783.94	+0.16%
Nov 13, 2025	¥3083.39	¥3106.09	+0.74%
Aug 06, 2025	¥3015.52	¥3025.23	+0.32%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Meiji Holdings Co Ltd (JP:2269) report earnings?

Meiji Holdings Co Ltd (JP:2269) is schdueled to report earning on Aug 11, 2026, TBA (Confirmed).

What is Meiji Holdings Co Ltd (JP:2269) earnings time?

Meiji Holdings Co Ltd (JP:2269) earnings time is at Aug 11, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Meiji Holdings Co Ltd stock?

The P/E ratio of Meiji Holdings Co is N/A.

What is JP:2269 EPS forecast?

JP:2269 EPS forecast for the fiscal quarter 2027 (Q1) is 53.09.